Author response: Personalizing acute therapies for ischemic stroke: Thrombolysis or thrombectomy?

I appreciate Dr. Munakomi’s comments, on our editorial,1 about the importance of public education to increase treatment opportunities for patients with acute ischemic stroke. At the same time, research to enhance diagnostic tests is needed and might help guide the most appropriate and effective treatments. The work by Bustamante et al.2 brings us one step closer to a potential blood biomarker that may, one day, help guide therapeutic decision making in the setting of acute ischemic stroke.

Source link

Related posts

A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex


Neurology: Challenges, opportunities, and the way forward


Clinical diagnoses among individuals with primary age-related tauopathy versus Alzheimer’s neuropathology


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World